Altimmune Initiates Pemvidutide Phase 3 Trial
Altimmune starts Phase 3 trial for Pemvidutide
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Altimmune starts Phase 3 trial for Pemvidutide